HomeIDXG • OTCMKTS
add
Interpace Biosciences Inc
Previous close
$1.00
Day range
$0.44 - $0.90
Year range
$0.44 - $3.54
Market cap
2.88M USD
Avg Volume
4.70K
P/E ratio
1.58
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 12.32M | 21.88% |
Operating expense | 5.84M | 21.37% |
Net income | 2.89M | 41.63% |
Net profit margin | 23.48 | 16.18% |
Earnings per share | — | — |
EBITDA | 3.17M | 24.49% |
Effective tax rate | -0.28% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.46M | -58.23% |
Total assets | 14.79M | 12.78% |
Total liabilities | 17.01M | -23.10% |
Total equity | -2.22M | — |
Shares outstanding | 4.42M | — |
Price to book | -2.00 | — |
Return on assets | 53.28% | — |
Return on capital | -4,726.15% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 2.89M | 41.63% |
Cash from operations | 1.18M | 3.86% |
Cash from investing | -129.00K | 9.15% |
Cash from financing | -1.71M | 32.58% |
Net change in cash | -652.00K | 57.50% |
Free cash flow | -6.14M | -25.57% |
About
Founded
1986
Headquarters
Website
Employees
111
